EP4598934A1 — 4'-thionucleoside analogues and their pharmaceutical use
Assigned to Gilead Sciences Inc · Expires 2025-08-13 · 1y expired
What this patent protects
Compounds, compositions, and methods useful for treating a viral infection, such as human immunodeficiency virus (HIV) infection, are disclosed. In particular, 4'-thionucleoside analogues and methods for their preparation and use as therapeutic or prophylactic agents are disclose…
USPTO Abstract
Compounds, compositions, and methods useful for treating a viral infection, such as human immunodeficiency virus (HIV) infection, are disclosed. In particular, 4'-thionucleoside analogues and methods for their preparation and use as therapeutic or prophylactic agents are disclosed.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.